Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Seronegative neuromyelitis optica spectrum disorder patients diagnosed using new diagnostic criteria.
[Therapeutic options for autoimmune encephalomyelitis].
Serum autoantibodies to myelin peptides distinguish acute disseminated encephalomyelitis from relapsing- remitting multiple sclerosis.
Demographic and clinical factors associated with changes in employment in multiple sclerosis.
Wnt and lithium: a common destiny in the therapy of nervous system pathologies?
Elevated serum anti-phosphatidylcholine IgG antibodies in patients with influenza vaccination-associated optic neuritis.
Parkinsonism associated with multiple sclerosis: A report of eight new cases and a review on the literature.
MObility ImproVEment with spasticity in multiple sclerosis in Europe: the MOVE 1 EU study.
Processing speed and working memory training in multiple sclerosis: A double-blind randomized controlled pilot study.
Hesperidin, a Citrus Flavonoid, Has the Ameliorative Effects Against Experimental Autoimmune Encephalomyelitis (EAE) in a C57BL/J6 Mouse Model.
Headache in multiple sclerosis and autoimmune disorders.
Subcutaneous immunoglobulin in CIDP and MMN: a different long-term clinical response?
Neuromuscular manifestations of west nile virus infection.
Insights into multiple sclerosis provided by non-coding RNAs: meeting summary from the symposium 'Non-coding RNAs in autoimmune disorders of the central nervous system' on 5 April 2013 in Warsaw, Poland.
Impact of a 10-week individualized exercise program on physical function and fatigue of people with multiple sclerosis: a pilot study.
Overcoming recruitment challenges in patients with multiple sclerosis: Results from an Italian survey.
The hepatocyte growth factor (HGF)-MET receptor tyrosine kinase signaling pathway: Diverse roles in modulating immune cell functions.
IL-1-induced Bhlhe40 identifies pathogenic T helper cells in a model of autoimmune neuroinflammation.
Segmented corpus callosum diffusivity correlates with the Expanded Disability Status Scale score in the early stages of relapsing-remitting multiple sclerosis.
Anti-MOG antibodies are under polygenic regulation with the most significant control coming from the C-type lectin-like gene locus.
Curcumin protects axons from degeneration in the setting of local neuroinflammation.
Interferon beta-related nephropathy and interstitial lung disease: a new association and a long-term warning.
C1-C2 X-Ray assessment of misalignment parameters in patients with Chronic Cerebra-spinal Venous Insufficiency and Multiple Sclerosis versus patients with other pathologies.
Type D, anxiety and depression in association with quality of life in patients with Parkinson's disease and patients with multiple sclerosis.
Ongoing clinical trials of TYSABRI
Pages
« first
‹ previous
…
440
441
442
443
444
445
446
447
448
…
next ›
last »